College of Pharmacy
Apotex Centre, 750 McDermot Ave. W.
University of Manitoba
Winnipeg, MB R3E 0T5
The overarching aim of Maruf Lab is to facilitate the development and implementation of evidence-informed precision medicine tools to guide the safe and effective use of medications with a primary focus on pediatric and the genetically underrepresented population. Our research program is collaborative and follows a teacher-scholar model that involves scholarly activities with students, innovative teaching approaches, and service activities to the institution, the profession, and society.
Our current research priorities are:
Dr. Abdullah Maruf (pronouns: he/him) is a pharmacist in training.
He has earned a Master's degree in clinical pharmacy & pharmacology and a PhD in toxicology in addition to receiving certifications in clinical research (Michener Institute at UHN), knowledge translation (Hospital for Sick Children), research administration (Canadian Association of Research Administrators), teaching (University of Toronto), and mentorship (iConnect, University of Toronto).
Dr. Maruf facilitated the development of pharmacogenetic research facilities in his home country - Bangladesh and published the first paper on drug-metabolizing enzyme polymorphisms in the Bangladeshi population during his Master of Pharmacy study at the University of Dhaka.
During his PhD at the University of Toronto, Dr. Maruf investigated the connections between inflammation and xenobiotic-induced liver injury and the roles of carbonyl metabolizing enzymes in health and disease.
Dr. Maruf was also involved in a study that aimed to examine the associations between biomarkers of methylmercury exposure, biomarkers of country food nutrients, including selenium, n-3 polyunsaturated fatty acids, polyphenols, and the risk of developing cardiometabolic diseases among the Inuit of Nunavik in his first postdoctoral position at Québec National Institute of Public Health.
In his second postdoctoral position at the University of Calgary, Dr. Maruf launched the first study in Canada to examine whether pharmacogenomics can answer why some children develop antidepressant-induced behavioural disinhibition while others do not.
Most recently, as a research scientist and a co-investigator, Dr. Maruf was instrumental in launching Canada’s first pharmacogenetic testing service in Alberta for children and youth seeking mental health care.
Visit Abdullah Maruf 's ORCID profile for a complete listing.